Skip to main content

Why Choose Inactivated (Fixed antigen) Reproductive vaccines?

Publications
Cattle
Authors

Chase, C.

The key to any good population immunity, allowed by mass vaccination with fixed antigen vaccines, is that a large enough percentatge of the animals (70-80%) develop good immunity so that the pathogen cannot spread easily in the herd.

There is one double-deleted gE-/tk- MLV BHV-1 vaccine available in Europe that is non-abortifacient and does not establish latency (HIPRABOVIS IBR Marker Live).

New and improved adjuvants were developed and used in veterinary vaccines. These adjuvants are the mixtures of molecules added to vaccines to make the immunity better and make the immune system work more efficiently to provide longer immunity (duration of protection). The discovery and development of better adjuvants was helped considerably by the work of researchers to develop HIV-AIDS vaccines.

Download this article
PDF